Company Search:
Advanced Search
Sponsored Links
Abivax Sa Company Snapshot
Abivax Sa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abivax Sa with three other miscellaneous service companies in Europe: Quantum Genomics SA (2014 sales of 12,000.00 Euros [US$14,167.68 ] ), Mologen AG of GERMANY (12,000.00 Euros [US$14,167.68 ] of which 100% was Goods & Services), and Silence Therapeutics Plc which is based in UNITED KINGDOM (£15,000.00 [US$19,531.20 ] of which 100% was RNA therapeutics).

Sales Analysis.
  Stock Performance Chart for Abivax Sa
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 19.06
(Figures in Euros )
1 Week -2.2%   13 Weeks 4.3%  
4 Weeks -13.0%   52 Weeks 112.7%  
Abivax Sa Key Data:
  Ticker: ABVX Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2014 Sales 14,488
(Year Ending Jan 2015).
Employees: 27
  Currency: Euros Market Cap: 232,744,881
  Fiscal Yr Ends: December Shares Outstanding: 12,211,169
  Share Type: Actions Ordinaires Closely Held Shares: 6,346,756
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.